Koyfin Home > Directory > Health Care > Kindred Biosciences > Total Equity

Kindred Biosciences Total Equity Chart (KIN)

Kindred Biosciences annual/quarterly Total Equity from 2012 to 2020.
  • Kindred Biosciences Total Equity for the quarter ending June 06, 2020 was $87m a -9.69% decrease of -8m year over year
  • Kindred Biosciences Total Equity for the last 12 months ending June 06, 2020 was $87m a -9.69% decrease of -8m year over year
  • Kindred Biosciences Annual Total Equity for 2019 was $82m a -11.34% decrease of -9m from 2018
  • Kindred Biosciences Annual Total Equity for 2018 was $91m a 7.16% increase of 7m from 2017
  • Kindred Biosciences Annual Total Equity for 2017 was $85m a 31.88% increase of 27m from 2016
Other Balance Sheet Metrics:
  • Kindred Biosciences Total Assets for the quarter ending September 09, 2018 was $113m a 19.90% increase of 23m year over year
  • Kindred Biosciences Other Liabilities for the quarter ending December 12, 2018 was $0m a -18.09% decrease of 0m year over year
View Chart On Koyfin

Quarterly KIN Total Equity Data

06/2020$87m
03/2020$61m
12/2019$82m
09/2019$95m
06/2019$108m
03/2019$120m
12/2018$91m
09/2018$104m
06/2018$116m
03/2018$76m

Annual KIN Total Equity Data

2019$82m
2018$91m
2017$85m
2016$58m
2015$76m
2014$99m
2013$63m
2012$1m